This year, World Malaria Day is running with the backdrop of countries around the world continuing to fight the COVID-19 pandemic.

The event, called “Improving care for chronic patients in lower-income countries: the patient journey,” will take place November 29, 2016, on the Novartis Campus in Basel, Switzerland and will also be webcast.

The event will take place on November 21 in Basel.

European Patient Innovation Summit publishes a position paper on Digital Health from a Patient Perspective with recommendations on digital health.

On April 9, 2019 Alcon becomes a separately traded company. Novartis and Alcon are now positioned to capitalize on significant growth opportunities and focus resources on their respective businesses and strategic priorities.

Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.

From January 13-16 2020, Novartis attended the J.P Morgan Healthcare Conference in San Francisco.

The World Health Organization (WHO) passed a resolution on psoriasis that creates an urgent call to action for the international community.

Novartis is partnering with the International Committee of the Red Cross (ICRC) to improve care and treatment for Syrian refugees in Lebanon suffering from chronic diseases.